SCHEMBL2484976

SCHEMBL2484976

CC(C)(F)C(=O)NC(C)(C)C(=O)Nc1nc(-c2ccc(F)cc2)c(Oc2ccc(F)cc2)s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
PKM P14618 1/20 0.45
RORC P51449 6/20 0.43
ROCK2 O75116 1/20 0.40
PTGDR2 Q9Y5Y4 2/20 0.40
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
ACHE P22303 2/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 2/20 0.37
NPC1 O15118 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
FPR2 P25090 1/20 0.36
SCN9A Q15858 1/20 0.36
GCK P35557 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2487593 0.93 ALDH1A1 (0.46) ALDH1A1PKMRORCROCK2PTGDR2
SCHEMBL2491039 0.91 ALDH1A1 (0.43) ALDH1A1PKMRORCROCK2PTGDR2
SCHEMBL2318514 0.89 RORC (0.45) ALDH1A1PKMRORCROCK2PTGDR2
SCHEMBL2490686 0.89 SMN1; SMN2 (0.45) ALDH1A1PKMRORCROCK2PTGDR2
SCHEMBL2317038 0.88 NPC1 (0.46) ALDH1A1PKMRORCROCK2PTGDR2
SCHEMBL2489968 0.88 ALDH1A1 (0.42) ALDH1A1PKMRORCROCK2PTGDR2
SCHEMBL2316452 0.87 ALDH1A1 (0.50) ALDH1A1PKMRORCROCK2PTGDR2
SCHEMBL2487147 0.86 RORC (0.45) ALDH1A1PKMRORCPTGDR2GCK
SCHEMBL2485747 0.86 ALDH1A1 (0.41) ALDH1A1PKMRORCROCK2PTGDR2
SCHEMBL2314978 0.86 NPC1 (0.42) ALDH1A1PKMRORCKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2559455-A1 Heteroaryl derivatives as DGAT1 inhibitors Novartis AG (CH) 2013-02-20 EP disclosed
EP-2548618-A2 Organic compounds Novartis AG (CH) 2013-01-23 EP disclosed
EP-2380631-A1 Heteroaryl derivatives as DGAT1 inhibitors Novartis AG (CH) 2011-10-26 EP disclosed